Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Meer inzicht in ontwikkeling van cognitieve problemen bij MS
aug 2021 | Multipele Sclerose